Caprock Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Caprock Group’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-70	Closed	-$77K	–	508
2017 Q3	$77K	Buy	+70	New	+$79.6K	0.02%	442

Other funds holding HSTO

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Caprock Group's HSTO Position: Q4 2017 in Review

Caprock Group sold out of Histogen Inc. Common Stock (HSTO) in Q4 2017, closing a stake of 70 shares — an estimated $77K sold.

Caprock Group first reported a position in HSTO in Q3 2017 and held it in 1 quarter. The position peaked at $77K in Q3 2017. 70 funds tracked by Wall St. Rank hold HSTO as of Q4 2017.

Caprock Group reported no remaining Histogen Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Caprock Group sold 70 Histogen Inc. Common Stock shares in Q4 2017, an estimated $77K.
Caprock Group first reported a position in Histogen Inc. Common Stock in Q3 2017 and held it in 1 quarter.
Caprock Group's Histogen Inc. Common Stock position peaked at $77K in Q3 2017.
70 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2017.

Based on Caprock Group's 13F filing for Q4 2017, filed 17 Jan 2018.